← ANALYSTS · TIPRANKS

Carter Gould · Cantor Fitzgerald

#2194among 12,504 TipRanks analysts★★★★★★★★★★
Hits 53% 173 of 329 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +6.3% Over a year after the rating, TipRanks’ measure
Our companies rated now 11 Buy / hold / sell: 7 / 4 / 0
Upside of the analyst’s targets +10.8% Average over 10 current targets, to the last price
The market’s answer to the ratings +0.2% Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 12on TipRanks 08:20 PCVXIWMVaxcyte · $10.3B Reiterated Buy $120 +88.6% −1.0%next day −5.4%
Oct 11on TipRanks Oct 12 08:20 MRKSPYMerck & Company · $358B Reiterated Hold $145 −0.7% 0.0%next day −2.4%
Oct 8on TipRanks 07:10 PFESPYPfizer · $168B Assigned Hold $27.00 → $28.00+3.7% −5.3% −0.2%next day +1.1% · 5 days +6.1%
Oct 8on TipRanks 07:10 BMYSPYBristol-Myers Squibb · $124B Assigned Hold $59.00 → $53.00−10.2% −11.3% +0.2%next day −1.4% · 5 days +1.9%
Oct 8on TipRanks 07:10 AMGNQQQSPYAmgen · $235B Assigned Hold $400 → $440+10.0% +1.7% −0.9%next day +1.2% · 5 days +6.8%
Oct 8on TipRanks 07:10 LLYSPYEli Lilly & Co · $1.2T Assigned Buy $1,410 → $1,440+2.1% +14.6% −1.2%next day +0.2% · 5 days +7.3%
Oct 8on TipRanks 07:10 ABBVSPYAbbVie · $501B Assigned Buy $285 → $290+1.8% +1.6% +0.8%next day +0.9% · 5 days +4.9%
Aug 4on TipRanks Aug 5 07:55 GILDQQQSPYGilead Sciences · $195B Reiterated Buy $155 −0.8% +1.3%next day −2.4% · 5 days +0.5%
Aug 4on TipRanks 07:56 VRTXQQQSPYVertex Pharmaceuticals · $129B Reiterated Buy $590 → $595+0.8% +19.1% −0.1%next day +1.5% · 5 days +10.7%
Jul 30on TipRanks Jul 31 08:19 REGNQQQSPYRegeneron · $82.0B Reiterated Buy $750 → $795+6.0% +0.5% +4.5%next day +2.6% · 5 days +1.0%
Feb 25on TipRanks Feb 26 09:40 CYTKIWMCytokinetics · $8.9B Reiterated Buy — — −11.1%next day +0.1% · 5 days +0.2%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗